Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results

Last Modified: 5/31/2007 First Published: 6/1/1999


1.		Phase III Randomized Study of IM-862 in Patients With Mucocutaneous AIDS-Related Kaposi's Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				NCI				AMC-013 AMC-KS-20898-01, NCT00003879

Last Modified: 2/1/2002 First Published: 7/1/2000


2.		Phase II Randomized Study of Fluorouracil With or Without IM-862 and Irinotecan With or Without IM-862 in Patients With Previously Untreated or Recurrent Metastatic Adenocarcinoma of the Colon or Rectum (Summary Last Modified 02/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				Over 18				NCI				LAC-USC-3C993 NCI-G00-1812, NCT00006037

Last Modified: 2/1/2002 First Published: 6/1/2001


3.		Phase II Randomized Study of Adjuvant Paclitaxel, Carboplatin, and IM-862 in Patients With Optimally Resected Stage III Ovarian Epithelial or Primary Peritoneal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				CYTRAN-IM862-302 FHCRC-5156, NCT00017303

Last Modified: 1/1/2001 First Published: 4/1/1999


4.		Phase I Study of IM-862 in Patients with Recurrent Ovarian Cancer (Summary Last Modified 01/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				LAC-USC-5O984 NCI-G99-1503, NCT00003773

Select All on One Page